NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ ...

Furthering its move into the neonatal space, this morning non-invasive patient monitoring device and sensor maker Masimo announced that it landed FDA clearance for its acoustic respiration sensor, the ...

Apple is prepared to remove the blood-oxygen sensor from its internet-connected watches if a court doesn’t give it more leeway while it pursues a bid to overturn a ruling that has blocked its use of ...

When a patient is receiving supplemental oxygen during surgery, there’s a risk that they’ll develop hyperoxia, where their arterial blood becomes oxygenated above normal levels, potentially leading to ...

Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...

Philips and Masimo have renewed a longstanding strategic partnership to develop patient care solutions. This time, the companies stated that their collaboration would primarily focus on advancing ...

A federal appeals court will allow a ban on Apple Watch Series 9 sales to resume on Thursday. A patent dispute between Apple and technology company Masimo over blood oxygen senor technology has ...

Apple is now planning to appeal an infamous ban that led to the Apple Watch Series 9 and Ultra 2 versions losing the blood oxygen sensor feature last year in court. The case saw the International ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

IRVINE, Calif. & RESTON, Va.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a leading medical technology innovator, and Practice Greenhealth, a prominent organization dedicated to advancing sustainability ...